Hjem › Småcellet lungekræft › Oregon
Småcellet lungekræft kliniske forsøg i Oregon
9 studier for Småcellet lungekræft søger deltagere på steder i Oregon.
Byer i Oregon
Officiel studietekst (engelsk)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04585750A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Willamette Valley Cancer Institute and Research Center /ID# 280617, Eugene
- Oregon Health and Science University /ID# 280071, Portland
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07365241A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- Providence Portland Medical Center ( Site 1101), Portland
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06780137A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Oncology Associates of Oregon, Eugene
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT06095505A Study of MGC026 in Participants With Advanced Solid Tumors
- Providence Cancer Institute, Portland
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06242470A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Providence Portland Medical Center, Portland
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT06203210A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Providence Portland Medical Center, Portland
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 15. jul. 2026 · NCT05652686Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Providence Newberg Medical Center, Newberg
- Providence Willamette Falls Medical Center, Oregon City
- Providence Portland Medical Center, Portland
- og 1 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. mar. 2026 · NCT06769126A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Oregon Health & Science University, Portland
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2025 · NCT06805825Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.